First Time Loading...

Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 33.45 USD -0.15% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

Medifast, Inc. engages in the provision of healthy living products and programs. [ Read More ]

The intrinsic value of one MED stock under the Base Case scenario is 63.62 USD. Compared to the current market price of 33.45 USD, Medifast Inc is Undervalued by 47%.

Key Points:
MED Intrinsic Value
Base Case
63.62 USD
Undervaluation 47%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medifast Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MED stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medifast Inc

Provide an overview of the primary business activities
of Medifast Inc.

What unique competitive advantages
does Medifast Inc hold over its rivals?

What risks and challenges
does Medifast Inc face in the near future?

Has there been any significant insider trading activity
in Medifast Inc recently?

Summarize the latest earnings call
of Medifast Inc.

What significant events have occurred
in Medifast Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medifast Inc.

Provide P/S
for Medifast Inc.

Provide P/E
for Medifast Inc.

Provide P/OCF
for Medifast Inc.

Provide P/FCFE
for Medifast Inc.

Provide P/B
for Medifast Inc.

Provide EV/S
for Medifast Inc.

Provide EV/GP
for Medifast Inc.

Provide EV/EBITDA
for Medifast Inc.

Provide EV/EBIT
for Medifast Inc.

Provide EV/OCF
for Medifast Inc.

Provide EV/FCFF
for Medifast Inc.

Provide EV/IC
for Medifast Inc.

Show me price targets
for Medifast Inc made by professional analysts.

What are the Revenue projections
for Medifast Inc?

How accurate were the past Revenue estimates
for Medifast Inc?

What are the Net Income projections
for Medifast Inc?

How accurate were the past Net Income estimates
for Medifast Inc?

What are the EPS projections
for Medifast Inc?

How accurate were the past EPS estimates
for Medifast Inc?

What are the EBIT projections
for Medifast Inc?

How accurate were the past EBIT estimates
for Medifast Inc?

Compare the revenue forecasts
for Medifast Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medifast Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medifast Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medifast Inc compared to its peers.

Compare the P/E ratios
of Medifast Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Medifast Inc with its peers.

Analyze the financial leverage
of Medifast Inc compared to its main competitors.

Show all profitability ratios
for Medifast Inc.

Provide ROE
for Medifast Inc.

Provide ROA
for Medifast Inc.

Provide ROIC
for Medifast Inc.

Provide ROCE
for Medifast Inc.

Provide Gross Margin
for Medifast Inc.

Provide Operating Margin
for Medifast Inc.

Provide Net Margin
for Medifast Inc.

Provide FCF Margin
for Medifast Inc.

Show all solvency ratios
for Medifast Inc.

Provide D/E Ratio
for Medifast Inc.

Provide D/A Ratio
for Medifast Inc.

Provide Interest Coverage Ratio
for Medifast Inc.

Provide Altman Z-Score Ratio
for Medifast Inc.

Provide Quick Ratio
for Medifast Inc.

Provide Current Ratio
for Medifast Inc.

Provide Cash Ratio
for Medifast Inc.

What is the historical Revenue growth
over the last 5 years for Medifast Inc?

What is the historical Net Income growth
over the last 5 years for Medifast Inc?

What is the current Free Cash Flow
of Medifast Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medifast Inc.

Financials

Balance Sheet Decomposition
Medifast Inc

Current Assets 224m
Cash & Short-Term Investments 150m
Receivables 8.7m
Other Current Assets 65.3m
Non-Current Assets 85.9m
PP&E 67.1m
Other Non-Current Assets 18.8m
Current Liabilities 92.3m
Accounts Payable 86.4m
Accrued Liabilities 5.9m
Non-Current Liabilities 16.1m
Other Non-Current Liabilities 16.1m
Efficiency

Earnings Waterfall
Medifast Inc

Revenue
1.1B USD
Cost of Revenue
-296.2m USD
Gross Profit
775.9m USD
Operating Expenses
-649.4m USD
Operating Income
126.4m USD
Other Expenses
-27m USD
Net Income
99.4m USD

Free Cash Flow Analysis
Medifast Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Medifast Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROE
74/100
Profitability
Score

Medifast Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Medifast Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
74/100
Solvency
Score

Medifast Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Medifast Inc

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 38.25 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.

Lowest
Price Target
35.35 USD
6% Upside
Average
Price Target
38.25 USD
14% Upside
Highest
Price Target
42 USD
26% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

MED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

MED Price
Medifast Inc

1M 1M
-10%
6M 6M
-53%
1Y 1Y
-63%
3Y 3Y
-84%
5Y 5Y
-75%
10Y 10Y
+35%
Annual Price Range
33.45
52w Low
31.35
52w High
107.06
Price Metrics
Average Annual Return 5.9%
Standard Deviation of Annual Returns 54.7%
Max Drawdown -90%
Shares Statistics
Market Capitalization 364.5m USD
Shares Outstanding 10 895 600
Percentage of Shares Shorted 37.11%

MED Return Decomposition
Main factors of price return

What is price return decomposition?

MED News

Other Videos

Last Important Events
Medifast Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Medifast Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Medifast Inc Logo
Medifast Inc

Country

United States of America

Industry

Consumer products

Market Cap

364.5m USD

Dividend Yield

19.78%

Description

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

Contact

MARYLAND
Owings Mills
11445 Cronhill Dr
+17327640619.0
https://www.medifast1.com

IPO

1993-12-30

Employees

984

Officers

Executive Chairman & CEO
Mr. Daniel R. Chard
Chief Financial Officer
Mr. James P. Maloney CPA
Chief Business Operations Officer
Mr. Anthony E. Tyree
Executive VP, General Counsel & Corporate Secretary
Mr. Jason L. Groves Esq.
Chief Field Operations Officer
Mr. Nicholas M. Johnson
VP of Finance & Chief Accounting Officer
Mr. Jonathan Barrett MacKenzie
Show More
Vice President of Investor Relations
Mr. Steven Zenker
Chief Human Resources Officer
Ms. Claudia C. Greninger
Show Less

See Also

Discover More
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 63.62 USD.

Is MED stock undervalued or overvalued?

Compared to the current market price of 33.45 USD, Medifast Inc is Undervalued by 47%.